Feed aggregator

Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study

Biospace news - Thu, 09/28/2023 - 02:00
Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study 9/28/2023

FDA Approves Viatris, Ocuphire’s Eye Drops to Reverse Pupil Dilation

Biospace news - Thu, 09/28/2023 - 02:00
FDA Approves Viatris, Ocuphire’s Eye Drops to Reverse Pupil Dilation 9/28/2023

Roche Doubles Down on Alzheimer’s, Huntington’s with $60M Ionis Partnership

Biospace news - Thu, 09/28/2023 - 02:00
Roche Doubles Down on Alzheimer’s, Huntington’s with $60M Ionis Partnership 9/28/2023

Ahmed Mousa: From the Hill to the C-Suite

Biospace news - Thu, 09/28/2023 - 02:00
Ahmed Mousa: From the Hill to the C-Suite 9/28/2023

Why Medical Science Liaisons Should Earn Board Certification

Biospace news - Thu, 09/28/2023 - 02:00
Why Medical Science Liaisons Should Earn Board Certification 9/28/2023

Gilead Axes Phase III Magrolimab Trial Based on Disappointing Data

Biospace news - Wed, 09/27/2023 - 02:00
Gilead Axes Phase III Magrolimab Trial Based on Disappointing Data 9/27/2023

AbbVie Terminates Caribou CAR-T Contract in Culling of Cancer Pipeline

Biospace news - Wed, 09/27/2023 - 02:00
AbbVie Terminates Caribou CAR-T Contract in Culling of Cancer Pipeline 9/27/2023

AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program

Biospace news - Wed, 09/27/2023 - 02:00
AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program 9/27/2023

Alto Reports Positive Phase II PTSD Data After Mid-Stage MDD Win

Biospace news - Wed, 09/27/2023 - 02:00
Alto Reports Positive Phase II PTSD Data After Mid-Stage MDD Win 9/27/2023

Astellas Withdrew Its Inflation Reduction Act Lawsuit—Will Other Companies Follow?

Biospace news - Wed, 09/27/2023 - 02:00
Astellas Withdrew Its Inflation Reduction Act Lawsuit—Will Other Companies Follow? 9/27/2023

mRNA Vaccine Manufacturing Comes to Africa

Biospace news - Wed, 09/27/2023 - 02:00
mRNA Vaccine Manufacturing Comes to Africa 9/27/2023

Rethinking Chemical Procurement in Biopharmaceuticals

Biospace news - Wed, 09/27/2023 - 02:00
Rethinking Chemical Procurement in Biopharmaceuticals 9/27/2023

Alfasigma Buys Beleaguered Intercept Pharmaceuticals in $800M Cash Deal

Biospace news - Tue, 09/26/2023 - 02:00
Alfasigma Buys Beleaguered Intercept Pharmaceuticals in $800M Cash Deal 9/26/2023

Ionis Notches Phase III Win in Rare Genetic Disease, Plans to Submit NDA

Biospace news - Tue, 09/26/2023 - 02:00
Ionis Notches Phase III Win in Rare Genetic Disease, Plans to Submit NDA 9/26/2023

Immunovant Stock Soars on Positive Phase I Autoimmune Antibody Data

Biospace news - Tue, 09/26/2023 - 02:00
Immunovant Stock Soars on Positive Phase I Autoimmune Antibody Data 9/26/2023

Novartis’ Lutathera Clears Phase III as Frontline Treatment for Rare Neuroendocrine Cancer

Biospace news - Tue, 09/26/2023 - 02:00
Novartis’ Lutathera Clears Phase III as Frontline Treatment for Rare Neuroendocrine Cancer 9/26/2023

Takeda Puts Nearly $600M on the Line for AcuraStem’s ALS Program

Biospace news - Tue, 09/26/2023 - 02:00
Takeda Puts Nearly $600M on the Line for AcuraStem’s ALS Program 9/26/2023

Appili Gets FDA Approval for Liquid, Oral Reformulation of Antibiotic Metronidazole

Biospace news - Tue, 09/26/2023 - 02:00
Appili Gets FDA Approval for Liquid, Oral Reformulation of Antibiotic Metronidazole 9/26/2023

Clene Reports Improved Long-Term Survival for ALS Patients Treated with Drug Candidate

Biospace news - Tue, 09/26/2023 - 02:00
Clene Reports Improved Long-Term Survival for ALS Patients Treated with Drug Candidate 9/26/2023

FDA Takes BrainStorm to Task Over Efficacy, Manufacturing Ahead of NurOwn Adcomm

Biospace news - Mon, 09/25/2023 - 02:00
FDA Takes BrainStorm to Task Over Efficacy, Manufacturing Ahead of NurOwn Adcomm 9/25/2023